RxGen routinely works with study sponsors to create and optimize translational models and to define and validate endpoints applicable to both preclinical and clinical study designs. We embrace a collaborative approach to new model development, harnessing existing capabilities and expertise and applying additional resources as required. Our ability to study a phenotypically diverse population of mixed sex and ages, or a phenotypic subpopulation defined with respect to specific study aims facilitates model development. Areas of existing interest and scientific attention include, but are not limited to:
- Neurodegenerative diseases
- Addiction
- Ocular disease
- Obesity
- Hypertension
- Diabetes
- Cardiac disease
- Osteoporosis
- Inflammation
- Angiogenesis
- Aging
- Developmental and Reproductive Toxicology
- Inquire about other models (contact us)
